A healthy 27-year-old Taiwanese man presented with extensive and recalcitrant plantar warts on his right foot for more than 10 years. When he was 14 years old, three discrete coin-sized thick scaly hyperkeratotic plaques with spiny rough surface were noted over his right sole. Skin biopsies had been performed twice in other medical institutes and verruca plantaris was diagnosed at that time. Various conventional therapies, including cryotherapy, electrocauterization, chemical cauterization, and local injection of interferon alfa-2b, were done; nevertheless, the cutaneous lesions were refractory and furthermore complicated with digital atrophy. Three years later, the skin lesions became diffuse hyperkeratotic whitish waxy plaques with involvement of the nonweight-bearing digits ( Figure 1A ). There was no family history of similar lesions.
On arrival at our hospital, the patient underwent a series of laboratory investigations. Complete blood count and antinuclear antibodies were found to be within normal limits, and human immunodeficiency virus antibody screen test was negative. Incisional skin biopsies were taken from the lesional skin of the right foot as well as normal skin of the left foot. Both of the specimens were sent for histological examination at our hospital. Consensus primers of human papillomavirus (HPV), MY11, and GP6þ were used for polymerase chain reaction assay. Then commercial EasyChip HPV blot (King Car Yuan Shan Institute, I-Lan, Taiwan) was used to determined specific genotype. The tissue from the nonlesional skin of the left foot was confirmed normal histopathologically, and no HPV DNA was detected. However, histopathologically, the skin taken from the lesional skin of the right foot revealed marked hyperkeratosis with parakeratotic columns over the tops of the papillae, acanthosis, papillomatosis, and elongation of rete ridge (Figure 2A ). Some scattered vacuolated cells with condensed keratohyalin granules in epidermis were found ( Figure 2B ). There was no evidence of malignancy in the sections examined ( Figure 2 ). In addition, the product of polymerase chain reaction displayed the occurrence of HPV DNA ( Figure 3 ) and was matched to genotype 52. Under the impression of verruca plantaris refractory to conventional treatments, oral acitretin (Neotigason, Actavis/Patheon Inc., Ontario, Canada) 0.5 mg/kg/d was prescribed for 6 months, subsequently tapered to half of previous dosage for one more month, and then discontinued. Marked improvement was observed after one month of treatment. The lesion was nearly clinically ameliorated after 6 months with few small residual hyperkeratotic areas (Figures 1BeD). The patient's triglyceride, cholesterol, and hepatic and renal function were checked every 3 months during the course of the treatment, and all results were within normal limits. Except for the presence of mild cheilitis and xerosis, no other adverse drug events were noted. The lesions were stationary and no relapse was observed after a 1-year period of follow-up.
Discussion
Warts, an extremely troublesome but common affliction, are caused by HPV and pose therapeutic challenges for both patients and physicians. HPV is composed of a large family of small doublestrand circular DNA viruses infecting epithelial cells and is hostspecific. HPV-52 reference genome was first isolated from a cervical intraepithelial neoplasia. Hybridization analysis with restriction fragments of HPV-52 showed collinearity with the HPV-33 genome.
1 Therefore, HPV-52 is considered a high-risk carcinogenic type and the sixth most common type in cervical cancer. Although cervical condylomata and anogenital warts are the most frequent clinical lesions associated with HPV-52, Fölster-Holst et al 2 first
identified the presence of HPV-52 from the papillomatous skin of a patient's groin. This indicates that HPV-52 could be found not only in mucosal areas but also in nonmucosal skin. There are multitudes of conventional treatment opinions regarding the combative therapies of warts, such as topical keratolytic agents, antimitotic agents (podophyllin, bleomycin, retinoids), topical immunomodulators, electrocauterization, laser surgery, cryosurgery, and photodynamic therapy. The choice of therapy, however, will be determined by cost, pain, success rate, ease of use, side effects, cosmesis, compliance, and patient preference. One of the most common first-line therapeutic methods, for instance, is cryosurgery as it is relatively safe and easily available. Despite of wide acceptance, the clearance rate for plantar warts is only 50% after executing every 3 weeks for a 3-month duration. 3 Furthermore, patients with plantar warts tend not to follow up owing to the high-relapse rate, persisting discomfort, and cutaneous secondary bacterial infection.
Retinoids exert diverse biological effects on cells, including the regulation of growth and differentiation. An inverse relationship was observed between concentration of retinoic acid and HPV DNA content within infected epithelial cells, suggesting an inhibitory effect on viral replication. 4 Lutzner and Blanchet-Bardon 5 proposed that the retinoids, by altering keratinization, are capable of inhibiting the replication and assembly of HPV within the affected cells, which requires human keratinocytes in an advanced state of differentiation.
In normal adult skin, keratin pairs K5/K14 and K1/K10 predominate in the basal layer and suprabasal compartment. Keratin K13 and K19 are usually expressed separately in adult epithelia. Retinoids have been proven to repress differentiationspecific keratins (K1/K10) and strikingly reinduce the expression of The lesions began to reduce within 2 weeks and were dramatically improved after 2 months. No sign of relapse was found after a 6-month period of follow-up.
In conclusion, oral synthetic retinoids can be a good alternative therapeutic method in treating extensive and recalcitrant viral warts that could bring about physical and psychosocial dysfunction in patients. 
